These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7056278

  • 1. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R, Erlanson P, Bodemar G, Norlander B, Fransson L, Strouth L.
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R, Erlanson P, Bodemar G, Walan A, Bertler A, Fransson L, Norlander B.
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [Abstract] [Full Text] [Related]

  • 3. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA, Jensen JB, Larsen NE, Hvidberg EF.
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA, Jensen JB, Nielsen LP, Larsen NE, Hvidberg EF.
    Nephron; 1983 Jun; 34(3):159-63. PubMed ID: 6877447
    [Abstract] [Full Text] [Related]

  • 6. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R, Bodemar G, Norlander B.
    Eur J Clin Pharmacol; 1979 Apr 17; 15(3):153-7. PubMed ID: 456399
    [Abstract] [Full Text] [Related]

  • 7. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R, Müller-Liebenau B, Somogyi A.
    Br J Clin Pharmacol; 1982 Sep 17; 14(3):421-30. PubMed ID: 7126415
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of guanfacine in patients undergoing haemodialysis.
    Kirch W, Kohler H, Axthelm T.
    Eur J Drug Metab Pharmacokinet; 1982 Sep 17; 7(4):277-80. PubMed ID: 6762301
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose-dependent pharmacokinetics of cimetidine in the rat.
    Adedoyin A, Aarons L, Houston JB.
    Xenobiotica; 1987 May 17; 17(5):595-604. PubMed ID: 3604263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J, Kantele S, Kivikko M, Häkkinen S, Harjola VP, Koskinen P, Pentikäinen PJ.
    Clin Pharmacokinet; 2007 May 17; 46(3):235-46. PubMed ID: 17328582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peritoneal dialysis clearance of cimetidine.
    Vaziri ND, Ness RL, Barton CH.
    Am J Gastroenterol; 1979 Jun 17; 71(6):572-6. PubMed ID: 313152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.